Cargando…
Clinical Insights into the Gastrointestinal Manifestations of COVID-19
The month of December 2019 became a critical part of the time of humanity when the first case of coronavirus disease 2019 (COVID-19) was reported in the Wuhan, Hubei Province in China. As of April 13th, 2020, there have been approximately 1.9 million cases and 199,000 deaths across the world, which...
Autores principales: | Kopel, Jonathan, Perisetti, Abhilash, Gajendran, Mahesh, Boregowda, Umesha, Goyal, Hemant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245177/ https://www.ncbi.nlm.nih.gov/pubmed/32447742 http://dx.doi.org/10.1007/s10620-020-06362-8 |
Ejemplares similares
-
Prevalence, Mechanisms, and Implications of Gastrointestinal Symptoms in COVID-19
por: Perisetti, Abhilash, et al.
Publicado: (2020) -
Addition of Tocilizumab to the Standard of Care Reduces Mortality in Severe COVID-19: A Systematic Review and Meta-Analysis
por: Boregowda, Umesha, et al.
Publicado: (2020) -
Serum Activity of Liver Enzymes Is Associated With Higher Mortality in COVID-19: A Systematic Review and Meta-Analysis
por: Boregowda, Umesha, et al.
Publicado: (2020) -
Racial and Gender-Based Differences in COVID-19
por: Kopel, Jonathan, et al.
Publicado: (2020) -
COVID-19 extrapulmonary illness – special gastrointestinal and hepatic considerations
por: Perisetti, Abhilash, et al.
Publicado: (2020)